Evidence map›Paper›PMID 31018137›Full record

ArticleCell reports2019

Disruption in A-to-I Editing Levels Affects C. elegans Development More Than a Complete Lack of Editing.

Nabeel S Ganem, Noa Ben-Asher, Aidan C Manning, Sarah N Deffit, Michael C Washburn, Emily C Wheeler, Gene W Yeo, Orna Ben-Naim Zgayer, Einav Mantsur, Heather A Hundley and 1 more

Abstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. ADARs mediate distinct RNA editing activity and gene regulation in thebioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Phylogenetic and structural analysis of Hydra ADAR.Archives of biochemistry and biophysics · 2025
    Article
  8. Article
  9. Article
  10. Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Lactobacillus for ribosome peptide editing cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nabeel S GanemFaculty of Biology, Technion-Israel Institute of Technology, Technion City, Haifa 32000, Israel.
Noa Ben-AsherFaculty of Biology, Technion-Israel Institute of Technology, Technion City, Haifa 32000, Israel.
Aidan C ManningMedical Sciences Program, Indiana University, Bloomington, IN 47405, USA.
Sarah N DeffitMedical Sciences Program, Indiana University, Bloomington, IN 47405, USA.
Michael C WashburnDepartment of Biology, Indiana University, Bloomington, IN 47405, USA.
Emily C WheelerDepartment of Cellular and Molecular Medicine, Stem Cell Program and Institute for Genomic Medicine, University of California, San Diego, San Diego, CA, USA.
Gene W YeoDepartment of Cellular and Molecular Medicine, Stem Cell Program and Institute for Genomic Medicine, University of California, San Diego, San Diego, CA, USA.
Orna Ben-Naim ZgayerFaculty of Biology, Technion-Israel Institute of Technology, Technion City, Haifa 32000, Israel.
Einav MantsurFaculty of Biology, Technion-Israel Institute of Technology, Technion City, Haifa 32000, Israel.
Heather A HundleyMedical Sciences Program, Indiana University, Bloomington, IN 47405, USA.
Ayelet T LammFaculty of Biology, Technion-Israel Institute of Technology, Technion City, Haifa 32000, Israel. Electronic address: ayeletla@technion.ac.il.

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Molecular mechanisms that regulate ADAR target recognition and RNA editing in vivoR01GM130759 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI HUNDLEY, HEATHER ANN · 2019 to 2023
$1.8M
Regulation of A-to-I editing in NeuronsF32GM119257 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI DEFFIT, SARAH N · 2017 to 2017
$42k
NIGMS NIH HHS F32 GM119257NIGMS NIH HHS R01 GM130759NIH HHS P40 OD010440
6 · The paper itself

Abstract

A-to-I RNA editing, catalyzed by ADAR proteins, is widespread in eukaryotic transcriptomes. Studies showed that, in C. elegans, ADR-2 can actively deaminate dsRNA, whereas ADR-1 cannot. Therefore, we set out to study the effect of each of the ADAR genes on the RNA editing process. We performed comprehensive phenotypic, transcriptomics, proteomics, and RNA binding screens on worms mutated in a single ADAR gene. We found that ADR-1 mutants exhibit more-severe phenotypes than ADR-2, and some of them are a result of non-editing functions of ADR-1. We also show that ADR-1 significantly binds edited genes and regulates mRNA expression, whereas the effect on protein levels is minor. In addition, ADR-1 primarily promotes editing by ADR-2 at the L4 stage of development. Our results suggest that ADR-1 has a significant role in the RNA editing process and in altering editing levels that affect RNA expression; loss of ADR-1 results in severe phenotypes.

Indexed as

RNA EditingAdenosineAdenosine DeaminaseAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsInosineMutationPhenotypeProteomeTranscriptomeAdenosineAdenosine DeaminaseAdr-1 protein, C elegansAdr-2 protein, C elegansCaenorhabditis elegans ProteinsInosineProteomeADARC. elegansgene expressionorganism developmenttranscriptomics

Identifiers

PMID31018137
PMCPMC8139731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.